FDA Import Refusal 823-0118040-0/1/1A — Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company
The FDA refused shipment 823-0118040-0/1/1A from Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company (United States) on Oct 19, 2006. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 118 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 19, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66VAY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118